On 2026-06-03, Avalyn Pharma Inc. (AVLN) announced earnings per share of -21.83 for the fiscal quarter ending 2026-03-31, missing the average analyst estimate of -16.38.

The next expected annoucement date for quarterly earnings is 2026-09-02, with an average estimated earnings per share of -0.96 for the fiscal quarter ending 2026-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.